Most Recent

Policymakers’ choice of seawater intakes highlights California’s troubling embrace of unproven technologies.

0 Comments

image: Opinion: Restoring Tomato Flavor

Opinion: Restoring Tomato Flavor

By | August 28, 2013

Commercial tomatoes rarely have that fresh vine-ripened flavor that everyone loves, but the ideal recipe for tomato taste is now known. Will growers embrace the new cultivars?

4 Comments

image: Opinion: Genomics in the Clinic

Opinion: Genomics in the Clinic

By | March 18, 2013

Next-generation sequencing diagnostics are already being used, and patients are ready.

0 Comments

image: Opinion: Paradoxical Amphibians

Opinion: Paradoxical Amphibians

By | February 7, 2013

New amphibian species are being discovered at an exciting rate, yet they are also the vertebrates most at risk of extinction.

0 Comments

image: Opinion: Learning from Transcriptomes

Opinion: Learning from Transcriptomes

By | November 28, 2012

In the largest microbial eukaryote genetic sequencing effort ever attempted, researchers are investigating the transcriptomes of 700 marine algae species.

1 Comment

image: Opinion: Talking Genomics

Opinion: Talking Genomics

By | November 13, 2012

The crucial importance of language in the debate over the regulation of direct-to-consumer genetic tests

1 Comment

image: Opinion: Fishy Deaths

Opinion: Fishy Deaths

By | October 29, 2012

Record fish die-offs in the Midwest call for a fresh look at how humans are disrupting the planet’s essential water cycle.

1 Comment

image: Opinion: Controlling Invasion

Opinion: Controlling Invasion

By | October 15, 2012

Remote sensing helps control an invasive giant weed that threatens ecosystems and border security.

2 Comments

Popular Now

  1. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  2. How Plants Evolved Different Ways to Make Caffeine
  3. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  4. ESP on Trial
    Foundations ESP on Trial

    In the 1930s, parapsychologist Joseph Banks Rhine aimed to use scientific methods to confirm the existence of extrasensory perception, but faced criticisms of dubious analyses and irreproducible results.

RayBiotech